Episode

Ep. 205: Neurofilaments as Biomarkers in ALS and frontotemporal dementia: From Bench to Bedside

Podcast
eanCast: Weekly Neurology
Published
Jun 14, 2026
Duration seconds
2046
Processing state
not_requested
Canonical source
https://eancast.podigee.io/205-neue-episode
Audio
https://audio.podigee-cdn.net/2515762-m-28380be5e6347be766f765de7c68333f.mp3?source=feed
JSON
/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-205-neurofilaments-as-biomarkers-in-als-and-frontotemporal-dementia-from-bench-to-bedside
Markdown
/podcast/eancast-weekly-neurology-5497158/ep-205-neurofilaments-as-biomarkers-in-als-and-frontotemporal-dementia-from-bench-to-bedside.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-205-neurofilaments-as-biomarkers-in-als-and-frontotemporal-dementia-from-bench-to-bedside/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-205-neurofilaments-as-biomarkers-in-als-and-frontotemporal-dementia-from-bench-to-bedside.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Moderator: Raffaele Dubbioso (Naples, Italy) Guest: Andrea Malaspina (London, UK) and Francesco Di Lorenzo (Rome, Italy) In this episode, Raffaele Dubbioso speaks with Andrea Malaspina and Francesco Di Lorenzo about the growing role of neurofilaments as biomarkers in amyotrophic lateral sclerosis and frontotemporal dementia. They discuss the biological basis and clinical interpretation of neurofilament measurements, their diagnostic and prognostic value, and their emerging role in identifying pre-symptomatic disease, monitoring progression, and supporting clinical trials in neurological practice.